Alivus Life Sciences Limited, previously known as Glenmark Life Sciences Limited, has announced the allotment of 4,190 equity shares of Rs. 2 each under the Glenmark Life Sciences Limited - Employee Stock Option Scheme (ESOP) 2021. The Nomination and Remuneration Committee approved this allotment in their meeting held on March 7, 2025. This move is part of the company’s ongoing strategy to incentivize and reward employees through stock options.

Impact on Paid-up Share Capital

Following the allotment of these shares, the company’s paid-up share capital has increased as follows:

• Before allotment: 12,253,286,862 equity shares of Rs. 2 each, totaling Rs. 24,50,65,724
• After allotment: 12,253,737,052 equity shares of Rs. 2 each, totaling Rs. 24,50,74,104

This allotment reflects a minor increase in the total equity base, which is part of the employee benefits scheme aimed at boosting employee engagement and retention.

Regulatory and Compliance Details

The SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 require companies to provide certain details related to ESOP allotments. In this case, the company has filed the requisite statement with the exchanges in compliance with Regulation 10(b) on July 19, 2024. The details provided to the exchanges are as follows:

• BSE Filing Number: DSC/IPO/AK/ESOP-IP/3281/2024-25
• NSE Filing Number: NSE/LIST/42891

The equity shares allotted are identical to existing shares, and there are no lock-in restrictions placed on these shares.

Details of Allotment and Share Information

• Shares allotted: 4,190
• Exercise price per share: Rs. 716
• Premium per share: Rs. 714
• Total issued share capital after this issue: Rs. 24,50,74,104
• ISIN number for shares: INE03Q201024
• Shares are identical to existing shares: Yes, they rank pari passu (equal in all respects).

Conclusion

This allotment is part of the company’s efforts to reward employees under the ESOP scheme, which is a key component of Alivus Life Sciences' compensation strategy. Investors and stakeholders will see a slight increase in the total equity shares and paid-up capital, but this move aligns with the company’s overall employee engagement and long-term growth objectives.